Ironwood Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Geoff Meacham. I'm the senior biopharma analyst here, and we are thrilled to have Ironwood, Ironwood Pharmaceuticals. And speaking on behalf of Ironwood up on stage here is Mark Mallon, who is CEO; and then also Tom McCourt, who's Chief Commercial Officer. So Mark's going to give us just a few slides as a background, then we'll do a Q&A fireside chat here. Mark?
All right. Thanks. Thanks, Geoff. And I'd like to thank Barclays and Geoff for the opportunity to speak here this afternoon at the conference. It's a very exciting time for Ironwood.
What I'll do is just very briefly give you an update on the spin-off and the split of the company with the launching of really 2 new companies, Ironwood and Cyclerion, and give you an update on how that process is going and then say a couple of words about Ironwood that Tom and I represent. Tom, as you've heard, is our President and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
